Acute alloxan renal toxicity in the rat initially causes degeneration of thick ascending limbs of henle

Journal of Toxicologic Pathology

Volumn 30, Issue 1, 2017, Pages 7-13

  Terayama, Yui ^a   Kodama, Yasushi ^b   Matsuura, Tetsuro ^a   Ozaki, Kiyokazu ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Acute renal toxicity; Alloxan; Rat; Tubular necrosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALLOXAN; AQUAPORIN 1; GLUCOSE TRANSPORTER 2; PROHIBITIN;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; HENLE LOOP; KIDNEY OUTER MEDULLA; KIDNEY TUBULE EPITHELIUM; MALE; MITOCHONDRION SWELLING; NEPHROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 85010445032     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.2016-0035     Document Type: Article

References (14)

1. Evan AP, Mong SA, Connors BA, Aronoff GR, and Luft FC. The effect of alloxan, and alloxan-induced diabetes on the kidney. Anat Rec. 208: 33-47. 1984.
2. Vargas L, Friederici HH, and Maibenco HC. Cortical sponge kidneys induced in rats by alloxan. Diabetes. 19: 33-44. 1970.
3. Bruckmann G, and Wertheimer E. Alloxan studies; the action of alloxan homologues and related compounds. J Biol Chem. 168: 241-256. 1947.
4. Zhang L, Terayama Y, Nishimoto T, Kodama Y, and Ozaki K. Acute alloxan toxicity causes granulomatous tubulointerstitial nephritis with severe mineralization. J Toxicol Pathol. 29: 261-264 2016.
5. Beveridge JM, and Johnson SE. Studies on diabetic rats: the production of cardiovascular and renal disease in diabetic rats. Br J Exp Pathol. 31: 285-293. 1950.
6. Bauchet AL, Masson R, Guffroy M, and Slaoui M. Immu-nohistochemical identification of kidney nephron segments in the dog, rat, mouse, and cynomolgus monkey. Toxicol Pathol. 39: 1115-1128. 2011.
7. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 51: 216-226. 2008.
8. Boquist L. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses. Acta Pathol Microbiol Scand [A]. 85A: 219-229. 1977.
9. Boquist L, and Boström T. Alloxan effects on mitochondria in vitro, studied with regard to inhibition of mitochondrial aconitase. Diabete Metab. 11: 232-237. 1985.
10. Bedford JJ, Leader JP, and Walker RJ. Aquaporin expression in normal human kidney and in renal disease. J Am Soc Nephrol. 14: 2581-2587. 2003.
11. Kashgarian M, Biemesderfer D, Caplan M, and Forbush B. Monoclonal antibody to Na,K-ATPase: immunocyto-chemical localization along nephron segments. Kidney Int. 28: 899-913. 1985.
12. Elsner M, Tiedge M, Guldbakke B, Munday R, and Lenzen S. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Diabetologia. 45: 1542-1549. 2002.
13. Weaver DC, McDaniel ML, and Lacy PE. Alloxan uptake by isolated rat islets of Langerhans. Endocrinology. 102: 1847-1855. 1978.
14. Gorus FK, Malaisse WJ, and Pipeleers DG. Selective uptake of alloxan by pancreatic B-cells. Biochem J. 208: 513-515. 1982.